ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Dr. Angela Smith discusses FDA approval of Jelmyto for low-grade UTUC"
Episode Synopsis
This is episode's guest is Dr. Angela B. Smith, Co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital; Director of Urologic Oncology in the UNC Department of Urology; and Associate Professor of Urology at UNC School of Medicine. A member of the study advisory committee for UroGen Pharma, Smith discusses the recent FDA approval of Jelmyto, which is the first therapy for the treatment of low-grade upper tract urothelial cancer.
More episodes of the podcast Urology Times Podcasts
Speaking of Urology: Patient-centered insights from the PKIDS trial in pediatric stone disease
09/10/2025
The Expert APProach: Training to Retain APPs in Urology, with J. Brandon Arruda, APRN, AGNP-C, CUNP
03/10/2025
Pearls & Perspectives: Theranostics and Beyond in Prostate Cancer, with Vahan Kassabian, MD
23/09/2025
In God we trust